Regulatory considerations for the development of autologous induced pluripotent stem cell therapies

Author： Carpenter Melissa K Couture Larry A

ISSN： 1746-0751

Source： Regenerative Medicine, Vol.5, Iss.4, 2010-07, pp. : 569-579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induced pluripotent stem cell technology for generating photoreceptors

By Boucherie Céédric Sowden Jane C Ali Robin R

Regenerative Medicine, Vol. 6, Iss. 4, 2011-07 ,pp. : 469-479

Future Medicine

Access to resources Recommend Favorite

Patent Eligibility of Induced Pluripotent Stem Cell Theranostics

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 4, 2013-04 ,pp. : 318-320

John Wiley & Sons Inc

Access to resources Recommend Favorite

Promises and challenges of the first clinical-grade induced pluripotent stem cell bank

By Ilic Dusko Stephenson Emma

Regenerative Medicine, Vol. 8, Iss. 2, 2013-03 ,pp. : 101-102

Future Medicine

Access to resources Recommend Favorite

Are we there yet? Navigating roadblocks to induced pluripotent stem cell therapy translation

By Parker Sarah L Perlingeiro Rita CR

Regenerative Medicine, Vol. 8, Iss. 4, 2013-07 ,pp. : 389-391

Future Medicine

Access to resources Recommend Favorite

Recent Patents on MicroRNA-Induced Pluripotent Stem Cell Generation

Recent Patents on Regenerative Medicine, Vol. 3, Iss. 1, 2013-01 ,pp. : 5-16

Bentham Science Publishers

Access to resources Recommend Favorite